ARCHIVES

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

This article is from The Cancer Letter archive.

Vol. 36 No. 41 | November 12, 2010

Download PDF Visit The Full Archive

Related Articles

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

October 22, 1982

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011